Chairman and CEO Mark Chandler recently disclosed that researchers within Luminex Corporation are developing new detection capabilities that would permit its LabMap system to “simultaneously perform a broad range of cellular, microbial, and related tests, such as complete blood counts (CBC) and bacterial analysis. The company recently filed an initial patent application covering aspects of …
“July 23, 2001 Intelligence: Late Breaking Lab News” Read More »
To access this post, you must purchase The Dark Report.